BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10965215)

  • 1. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia.
    Fideleff HL; Ruibal G; Boquete H; Pujol A; Sequera A; Sobrado P
    Horm Res; 2000; 53(1):16-9. PubMed ID: 10965215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroprolactinemia revisited: a study on 106 patients.
    Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
    J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macroprolactinemia, a variety of hyperprolactinemia. Apropos of 5 cases].
    Recchi V; Hieronimus S; Creisson G; Freychet P; Morange I; Canivet B
    Rev Med Interne; 1997; 18(4):320-3. PubMed ID: 9161560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
    Hattori N
    J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening and detection of patients with macroprolactinemia by application of polyethylene glycol precipitation method].
    Chen YJ; Zhou YL; Xu L; Yan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):187-92. PubMed ID: 24782376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
    Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Dal Bosco F
    J Endocrinol Invest; 2003 Feb; 26(2):148-56. PubMed ID: 12739743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the nature of serum prolactin in two patients with macroprolactinemia.
    Carlson HE; Markoff E; Lee DW
    Fertil Steril; 1992 Jul; 58(1):78-87. PubMed ID: 1624027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
    Vilar L; Vilar CF; Lyra R; Freitas MDC
    Neuroendocrinology; 2019; 109(1):7-19. PubMed ID: 30889571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroprolactinemia: a new cause of hyperprolactinemia.
    Hattori N
    J Pharmacol Sci; 2003 Jul; 92(3):171-7. PubMed ID: 12890882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic hyperprolactinemia resulting from macroprolactinemia.
    Corenblum B
    Fertil Steril; 1990 Jan; 53(1):165-7. PubMed ID: 2295337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
    Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.